News & Updates

In older adults with mild cognitive impairment (MCI), daily supplementation with oral nicotinamide riboside (NR) at a dose of 1 g for 10 weeks appears to show a favourable safety profile and increases blood levels of NAD+* and associated metabolites, a phase II study suggests.

Pregnant women with epilepsy face considerably greater risk of severe morbidity as well as maternal and perinatal mortality, according to a study.

In the treatment of critically ill patients with acute organ dysfunction, use of the SGLT-2 inhibitor dapagliflozin in addition to standard care does not appear to improve clinical outcomes, according to a study.

While the MIND* diet has been shown to boost cognitive health, new research suggests that this effect is partially explained by reduced brain arteriosclerosis risk.

Liver transplantation (LT) in combination with chemotherapy, as opposed to chemotherapy alone, can provide a meaningful improvement in survival among patients with unresectable colorectal liver metastases, suggest the results of the TRANSMET trial presented at ESMO GI 2024.

A new patient achieves sustained HIV remission – the seventh in the world – following stem cell therapy for blood cancer and after stopping antiretroviral therapy (ART), adding to the roster of individuals with HIV who are inching their way towards a potential cure.

Treatment with cytisinicline for 12 weeks, in addition to behavioural support, is well tolerated and appears to help e-cigarette users to quit vaping, according to the results of the phase II ORCA-V1 trial.

Drinking coffee or tea daily appears to be associated with slower cognitive decline, particularly fluid intelligence, in older adults, according to a recent study presented at AAIC 2024.